The Importance of Tibial Artery Patency in the Rechanneling of the Femoral Artery

After rechanneling occluded superficial femoro-popliteal arteries, interventional physicians are left with the question of how to proceed with infrapopliteal disease. This work (soon to be published in Eur J Vasc Endovasc Surg) shows us the importance of achieving patency in tibial arteries so as to obtain better mid-term outcomes.

The gist is that, after an effort to rechannel a long, calcified chronic total occlusion in the superficial femoral artery, we must take a deep breath and make the same effort for the tibial arteries; otherwise, the job will be simply half way through.

 

This study included a total of 238 lower limbs in 199 patients with de novo superficial femoral artery chronic total occlusions treated with conventional nitinol stents between 2009 and 2015. These lower limbs were divided into 2 groups, group A (number of patent tibial arteries at baseline angiogram ≥2, 127 limbs in 104 patients) vs. group B (number of patent tibial arteries at baseline angiogram ≤1, 111 limbs in 95 patients).


Read also: Can We Discontinue Betablockers after AMI?


The additional efficacy of tibial artery patency after rechanneling the superficial femoral artery was evaluated by comparing B group subgroups (group B with patent tibial artery vs. without patent tibial artery). The primary endpoint was freedom from major events in the treated limb at 2 years, defined as a composite of repeat revascularisation and amputation.

 

Group A had a significantly higher event-free survival rate at 2 years compared with group B (80.9% vs. 43.5%; p < 0.001). This difference was mainly driven by the revascularization rate.


Read also: Less Bivalirudin and Minimal Use of Ultrasound for Puncture Is the Worldwide Trend in Transradial Access.


In the B group subgroup analysis, patients with tibial artery rechanneling (besides femoral artery rechanneling) had significantly higher event-free survival rates compared with patients who only underwent femoral artery rechanneling (65.5% vs. 26.2%; p = 0.001).

 

Conclusion

The presence of patent tibial arteries was an important predictor of events after the rechanneling of femoral arteries. Additional tibial artery angioplasty after femoral artery rechanneling is fundamental for the improvement of clinical outcomes.

 

Original title: The Importance of Patency of Tibial Run Off Arteries on Clinical Outcomes After Stenting for Chronic Total Occlusions in the Superficial Femoro-Popliteal Artery.

Reference: Yusuke Watanabe et al. Eur J Vasc Endovasc Surg (2018). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...